Japanese culture

Surgical And Respiratory Masks Market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030

Retrieved on: 
Wednesday, November 11, 2020

The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.

Key Points: 
  • The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.
  • North America dominates the revenue share of the global surgical and respiratory masks market, and is expected to be more lucrative with massive demand for surgical and respiratory masks to prevent contagious respiratory diseases.
  • The global surgical and respiratory masks market is experiencing consolidation activities by manufacturers, which include collaborations, acquisitions, and partnerships.
  • By product type, surgical masks are further segmented into basic surgical masks, anti-fog foam surgical masks, fluid/splash resistant surgical masks and others; and respirators are further segmented into single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs.

Surgical And Respiratory Masks Market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030

Retrieved on: 
Wednesday, November 11, 2020

The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.

Key Points: 
  • The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.
  • North America dominates the revenue share of the global surgical and respiratory masks market, and is expected to be more lucrative with massive demand for surgical and respiratory masks to prevent contagious respiratory diseases.
  • The global surgical and respiratory masks market is experiencing consolidation activities by manufacturers, which include collaborations, acquisitions, and partnerships.
  • By product type, surgical masks are further segmented into basic surgical masks, anti-fog foam surgical masks, fluid/splash resistant surgical masks and others; and respirators are further segmented into single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs.

Design Revealed for Renewal of the National Bonsai and Penjing Museum at the U.S. National Arboretum

Retrieved on: 
Tuesday, November 10, 2020

The design of the Bonsai and Penjing Museum establishes a pervasive grove of understory trees as the principal image and identity of the Museum.

Key Points: 
  • The design of the Bonsai and Penjing Museum establishes a pervasive grove of understory trees as the principal image and identity of the Museum.
  • Trey Trahan, FAIA,architect for the Bonsai and Penjing Museum and founding principal of Trahan Architects, said: "It's about deferring to the power of the Bonsai & Penjing.
  • The design elevates the National Bonsai & Penjing Museum to the world class experience befitting the collection, which includes priceless State gifts of trees and viewing stones."
  • Founded in 1982, the National Bonsai Foundation is a 501(c)(3) nonprofit that works in cooperation with the U.S. National Arboretum to supply financial, programmatic and curatorial support for the National Bonsai & Penjing Museum.

UNIQLO Debuts at China Import Expo with The Art and Science of LifeWear

Retrieved on: 
Tuesday, November 10, 2020

The event also marked the first time UNIQLO hosted TheArt and Science of LifeWear, a LifeWear global brand exhibition, in China, following similar events in New York, Paris and London in previous years.

Key Points: 
  • The event also marked the first time UNIQLO hosted TheArt and Science of LifeWear, a LifeWear global brand exhibition, in China, following similar events in New York, Paris and London in previous years.
  • At 1,500 square metersTheArt and Science of LifeWear was the largest exhibition space in the customer goods category of the CIIE.
  • Jalin Wu, Group Executive Officer of Fast Retailing and Chief Marketing Officer of UNIQLO Greater China, said, "UNIQLO is pleased to have introduced The Art and Science of LifeWear and its product and services innovations to consumers in China, and around the world, through the CIIE platform.
  • It is hard to believe that UNIQLO staged such an amazing performance for its first time at the exhibition.

UNIQLO Debuts at China Import Expo with The Art and Science of LifeWear

Retrieved on: 
Tuesday, November 10, 2020

The event also marked the first time UNIQLO hosted TheArt and Science of LifeWear, a LifeWear global brand exhibition, in China, following similar events in New York, Paris and London in previous years.

Key Points: 
  • The event also marked the first time UNIQLO hosted TheArt and Science of LifeWear, a LifeWear global brand exhibition, in China, following similar events in New York, Paris and London in previous years.
  • At 1,500 square metersTheArt and Science of LifeWear was the largest exhibition space in the customer goods category of the CIIE.
  • Jalin Wu, Group Executive Officer of Fast Retailing and Chief Marketing Officer of UNIQLO Greater China, said, "UNIQLO is pleased to have introduced The Art and Science of LifeWear and its product and services innovations to consumers in China, and around the world, through the CIIE platform.
  • It is hard to believe that UNIQLO staged such an amazing performance for its first time at the exhibition.

HanesBrands Proprietary Surgical Face Mask Receives Authorization by U.S. Food and Drug Administration

Retrieved on: 
Thursday, November 5, 2020

We are delighted to have this mask added to the FDAs Emergency Use Authorization for surgical masks during the COVID-19 pandemic, said Mike Abbott, HanesBrands director of research and development.

Key Points: 
  • We are delighted to have this mask added to the FDAs Emergency Use Authorization for surgical masks during the COVID-19 pandemic, said Mike Abbott, HanesBrands director of research and development.
  • In accordance with the FDA surgical mask Emergency Use Authorization, HanesBrands disposable, single-use surgical masks:
    Have not been FDA cleared or approved.
  • In accordance with the FDA face coverings Emergency Use Authorization, HanesBrands government cloth face coverings and consumer face masks:
    Have not been FDA cleared or approved.
  • Connect with the company via social media: Twitter ( @hanesbrands ), Facebook ( www.facebook.com/hanesbrandsinc ), Instagram ( @hanesbrands ), and LinkedIn ( @Hanesbrandsinc ).

Eisai and JD Health Establish JV Company in China to Implement Health Service Platform

Retrieved on: 
Wednesday, October 28, 2020

TOKYO, Oct 28, 2020 - (JCN Newswire) - Eisai Co., Ltd. and JD Health announced today that Eisai's Chinese subsidiary Eisai China Inc. and JD Health have established a joint venture company, Jingyi Weixiang (Shanghai) Health Industry Development Limited Company, to build a Health Service Platform for the elderly in China.

Key Points: 
  • TOKYO, Oct 28, 2020 - (JCN Newswire) - Eisai Co., Ltd. and JD Health announced today that Eisai's Chinese subsidiary Eisai China Inc. and JD Health have established a joint venture company, Jingyi Weixiang (Shanghai) Health Industry Development Limited Company, to build a Health Service Platform for the elderly in China.
  • JD Health has a strong e-commerce business foundation, internet medical service know-how, and logistics infrastructure covering 99% of vast regions in China.
  • Eisai and JD Health have now established a joint venture company in China that integrates the strengths of both companies, with JD Health investing 51% and Eisai China investing 49%.
  • The One-Stop Health Service Platform will provide the following four core services online in China.

New Data on Increasing Cloth Mask Effectiveness

Retrieved on: 
Tuesday, October 27, 2020

If everyone uses effective masks, the benefit is compounded because each person's mask reduces the number of particles they transmit, and also the number of particles they inhale.

Key Points: 
  • If everyone uses effective masks, the benefit is compounded because each person's mask reduces the number of particles they transmit, and also the number of particles they inhale.
  • The new study in Risk Analysis suggests that the effectiveness of cloth masks can be improved by using a non-woven material such as cotton batting.
  • Increasing the surface area of fibers exposed to moving air improves filtering efficiency because the smaller particles are absorbed onto the fibers.
  • The case for universal cloth mask adoption and policies to increase supply of medical masks for health workers.

The Good Camp™ Helped Save Nonprofit CatCafe Lounge from COVID Closure

Retrieved on: 
Tuesday, October 27, 2020

"My dog Molly is a rescue animal and I've volunteered at organizations like Kristi's.

Key Points: 
  • "My dog Molly is a rescue animal and I've volunteered at organizations like Kristi's.
  • CCL has helped save over 450 cats in just a couple of years, and hopes to continue for years to come.
  • Founded in early 2020, The Good Camp is a small but mighty group of marketers on a mission to help people make better choices.
  • As LAs only nonprofit Cat Cafe, our core belief is to make our cats rich, not people.

Pulmatrix Announces Commercial Launch of FEND, an OTC Nasal Hygiene Product Proven to Reduce Airborne Respiratory Droplets, with Partner Sensory Cloud

Retrieved on: 
Wednesday, October 21, 2020

FEND is a potentially important new hygiene option beyond masks to combat the ongoing COVD-19 pandemic.

Key Points: 
  • FEND is a potentially important new hygiene option beyond masks to combat the ongoing COVD-19 pandemic.
  • Pulmatrix licensed the rights to the Company's NasoCalm proprietary formulations (PUR003 and PUR006) to Sensory Cloud, now integral to the product FEND, with Sensory Cloud to market and distribute FEND, and Pulmatrix to receive escalating royalties, upon commencement of sales.
  • Importantly, FEND has the potential to address airborne submicron droplets not captured by surgical masks that may increase infection threat, particularly in indoor environments.
  • Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology.